• Need to rely on intermediate outcomes (diagnostic accuracy), requiring inferences regarding effects on clinical/patient outcomes |
• Methodological limitations in diagnostic accuracy studies |
• Inconsistency in diagnostic accuracy estimates, with lack of reliable methods for measuring statistical heterogeneity |
• Imprecision in some diagnostic accuracy estimates |
• Difficulty in determining accuracy of some standard assays due to the absence of an alternative reference standard |
• No standardized/validated criteria for clinically important differences in diagnostic accuracy |
• Wide variety of commercially available HBV and HCV test assays with variable testing and regulatory oversight |
• How to incorporate/weigh findings from predictive modeling studies |
• How to weigh trade-offs between lower diagnostic accuracy and lower costs, increasing testing access, uptake, and linkage to care; greater feasibility; and/or values and preferences |